Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: The promotion of therapeutic adherence is considered as an integral component of pharmaceutical care practice and patient healthcare. It has been shown that despite effective methods of treatment, 50% of diabetic patients fail to achieve satisfactory glycemic control, which leads to accelerated development of complications and increased mortality. Clinical experience indicates that no improvement of metabolic control is possible without patients' adherence to medications. This study sought to examine the rate of medication adherence and different factors affecting it among Type 2 diabetic patients in Egypt. METHODS: A total of 226 Type 2 diabetic patients who fulfilled the inclusion criteria were recruited in the current study. Adherence to the treatment was evaluated during patients' hospitalization in the Outpatient Clinics of Internal Medicine Department at University of Mansoura, Egypt. The medication adherence has been assessed during a personal interview with each patient using a multiple-choice graded questionnaire. RESULTS: In the study population, the adherence rates to medication, dietary/exercise and appointment were observed to be suboptimal. The most important social factors that were significantly affecting adherence rate to the prescribed oral hypoglycemic agent(s) included marital status (P < 0.01), family support (P < 0.01), and socio-economical level (P < 0.01). Other patient factors that were significantly affecting therapeutic adherence were patient knowledge about the disease (P < 0.01), patients' beliefs and motivation about prescribed drugs (P < 0.01), and regularity of patients' self monitoring of blood glucose level (P < 0.01). Among drug factors which found to affect significantly the rate of medication adherence are the number of drugs taken (P < 0.05), complexity of drug regimen (P < 0.01), and the presence of drug side effects (P < 0.01). Economical factor played an equally important role. Direct and indirect care costs in relation to patients' income were significantly affecting the rate of adherence to medication (P < 0.01). CONCLUSIONS: An improvement with the adherence to oral hypoglycemic agent(s) may be achieved through continuing patient education about diabetes, improvement of patients' economical levels as well as a reduction in the cost of medication. Pharmaceutical companies have to be involved and pharmacists have to be payed for helping chronically ill patients to take their medicines correctly for improving clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220 · cited 1×
“…of blood glucose level, number of drug taken, drug regimen, experience side effects, and direct and indirect care costs in relation to patient income; (iv) assessment of patient adherence to medication using the Measure Treatment Adherence (MTA) Scale developed by Delgado and Lima (2001).”
MethodThe association between diabetes metabolic control and drug adherence in an indigent population
Schectman, J. M., Nadkarni, M. M., & Voss, J. D. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1015 · Cited by 373 · cited 2×
“The studies so far have generally evaluated medication adherence and its effects on metabolic control of diabetes, while factors affecting medication adherence itself have been analyzed less frequently (Schectman-Joel et al., 2002).”
BackgroundSelf-monitoring of blood glucose by adults with diabetes in the United States population
Harris, M. I., Cowie, C. C., & Howie, L. J. (1993) · Diabetes Care · doi:10.2337/diacare.16.8.1116 · Cited by 158
Cited by
Horne, R., Chapman, S. C. E., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080633 · Cited by 1,174
Adherence to diabetes medication: a systematic review
Krass, I., Schieback, P., & Dhippayom, T. (2015) · Diabetic Medicine · doi:10.1111/dme.12651 · Cited by 453
Jaam, M., Ibrahim, M. I. M., Kheir, N., & Awaisu, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.015 · Cited by 62
Adherence to oral anti-diabetic drugs among patients attending a Ghanaian teaching hospital
Bruce, S. P., Acheampong, F., & Kretchy, I. (2015) · Pharmacy Practice · doi:10.18549/pharmpract.2015.01.533 · Cited by 52
Metadata
- Authors
- Shams, M. E. E., & Barakat, E. A. M. E.
- Venue
- Saudi Pharmaceutical Journal
- Published
- 2010-10
- Volume
- 18
- Issue
- 4
- Pages
- 225-232
- ISSN
- 1319-0164 (ISSN-L)
- OpenAlex
- W1964443432
- Cited by
- 92
- References
- 4
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. https://app.cochat.ai/papers/10.1016/j.jsps.2010.07.004
- The paper
- Shams, M. E. E., & Barakat, E. A. M. E. (2010). Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2010.07.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.